Brief: Organon Q4 Adjusted EPS USD 0.63 Vs. IBES Estimate USD 0.73
12/02/2026 12:30
Feb 12 (Reuters) - Organon Q4 revenue USD 1,507 million vs. IBES estimate USD 1,539 million. Q4 adjusted EBITDA margin 25.4% Q4 net income USD -205 million Q4 EPS USD -0.79 Q4 adjusted net income USD 165 million vs. IBES estimate USD 192.6 million Q4 gross margin 49.2% outlook FY revenue USD 1,900 million
Recent news on Organon & Co.
See all newsIndia's Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say
Brief: Organon & Co Says It Does Not Expect To Record Milestone Expense In Q3 2026
India's Persistent Systems plans debut rupee debt sale to fund acquisition, bankers say
India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
Organon & Co reports results for the quarter ended June 30 - Earnings Summary